Sylvester Comprehensive Cancer Center

E-mail a Friend

Paul Martin, M.D.

General Information

Paul  Martin, M.D.

Contact

Languages

  • English

Certifications

  • American Board of Internal Medicine
  • American Board of Internal Med-Gastroenterology
  • American Board of Internal Med-Transplant Hepatology

Specialties

  • Gastroenterology - Internal Medicine
  • Hepatology - Internal Medicine
  • Internal Medicine

Roles

  • Chief, Division of Hepatology
  • Professor of Medicine

Education

2009 DMed
National University of Ireland
1989
Liver Diseases Section, NIDDK, NIH
1987 Fellowship
Sunnybrook Medical Center, University of Toronto
1986 Fellowship
Queen's University
1984 Associate Chief Medical Resident
University of Alberta
1983 Residency
University of Alberta
1979 Internship
St. Vincent's Hospital
1978 M.B., B. Ch., B.A.O.
University College, Dublin, National University of Ireland

Publications

  • Fabrizi F, Martin P, Dixit V, Messa P. Meta-analysis of observational studies: hepatitis C and survival after renal transplant. J Viral Hepat. 2014 May.
  • Martin P, DiMartini A, Feng S, Brown R, Fallon M. Evaluation for liver transplantation in adults: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation. Hepatology. 2014 Feb 25.
  • Levy C, Naik J, Giordano C, Mandalia A, O'Brien C, Bhamidimari KR, Schiff ER, Martin P. Hispanics with Primary Biliary Cirrhosis Are More Likely to Have Features of Autoimmune Hepatitis and Reduced Response to Ursodeoxycholic Acid Than Non-Hispanics. Clin Gastroenterol Hepatol. 2013 Dec 17.
  • Brennan BJ, Wang K, Blotner S, Magnusson MO, Wilkins JJ, Martin P, Solsky J, Nieforth K, Wat C, Grippo JF. Safety, tolerability, and pharmacokinetics of ribavirin in hepatitis C virus-infected patients with various degrees of renal impairment. Antimicrob Agents Chemother. 2013 Dec
  • Fabrizi F, Lunghi G, Alongi G, Aucella F, Barbisoni F, Bisegna S, Mangano S, Romei-Longhena G, Artoni A, Bettoni G, Messa P, Martin P. Kinetics of Hepatitis B Virus Load During Haemodialysis Sessions and a-Interferon: A Prospective Study. Kidney Blood Press Res. 2013 Sep 4
  • Couto CA, Gelape CL, Calmet F, Martin P, Levy C. Effect of ethnicity on liver transplant for hepatocellular carcinoma. Exp Clin Transplant. 2013 Aug.
  • Morris CJ, Hill M, de Medina M, Herman C, Cloherty GA, Martin P. Comparison of detection and quantification of HBV DNA in chronic HBeAg negative and positive patients by Abbott RealTime HBV and Roche Cobas TaqMan HBV assays. J Virol Methods. 2013 Jul 5.
  • Jacobs E, Singh V, Damluji A, Shah NR, Warsch JL, Ghanta R, Martin P, Alfonso CE, Martinez CA, Moscucci M, Cohen MG. Safety of transradial cardiac catheterization in patients with end-stage liver disease. Catheter Cardiovasc Interv. 2013 May 31.
  • Teperman LW, Poordad F, Bzowej N, Martin P, Pungpapong S, Schiano T, Flaherty J, Dinh P, Rossi S, Subramanian GM, Spivey J. A randomized trial of emtricitabine/tenofovir disoproxil fumarate after hepatitis B immunoglobulin withdrawal post-liver transplant. Liver Transpl. 2013 Feb 27.
  • Talal AH, Lafleur J, Hoop R, Pandya P, Martin P, Jacobson I, Han J, Korner EJ. Absolute and relative contraindications to pegylated-interferon or ribavirin in the US general patient population with chronic hepatitis C: results from a US database of over 45,000 HCV-infected, evaluated patients. Aliment Pharmacol Ther. 2013 Jan 7.
  • Hibi T, Sageshima J, Molina E, Ciancio G, Nishida S, Chen L, Arosemena L, Mattiazzi A, Guerra G, Kupin W, Tekin A, Selvaggi G, Levi D, Ruiz P, Livingstone AS, Roth D, Martin P, Tzakis A, Burke GW. Predisposing Factors of Diminished Survival in Simultaneous Liver/Kidney Transplantation. Am J Transplant. 2012 Nov;12(11):2966-2973
  • Fabrizi F, Dixit V, Messa P, Martin P. Interferon therapy of acute hepatitis C in dialysis patients: meta-analysis. J.Viral Hepatology. 2012 Nov;19(11):784-91.
  • Fabrizi F, Dixit V, Martin P, Messa P. The Evidence-Based Epidemiology of HCV-associated Kidney Disease. Int J Artif Organs. 2012 Sep; 35(9): 621-8.
  • Martin P, Couto C, Levy C, Hill M, Morris C, De Medina M, Sanborn M, Cloherty G, Schiff E. High frequency of genotype D and spontaneous HBV Genomic Mutations among Haitians in a Multiethnic North American population. J Clin Gastroenterol. 2013 Jan; 57(1):83-8.
  • Fabrizi F, Dixit V, Martin P, Messa P. Erthropoietin Use and Immunogenicity of Hepatitis B Virus Vaccine in Chronic Kidney Disease Patients: A Meta-Analysis. Kidney Blood Pressure Press Res. 2012 Jul 14:35(6):504-510
  • Fabrizi F, Dixit V, Martin P, Messa P. Erthropoietin Use and Immunogenicity of Hepatitis B Virus Vaccine in Chronic Kidney Disease Patients: A Meta-Analysis. Kidney Blood Pressure Press Res. 2012 Jul 14:35(6):504-510
  • Carrion AF, Martin P. Viral Hepatitis in the Elderly. Am J Gastroenterol. 2012 May;107(5):691-697
  • Fabrizi F, Martin P, Dixit V, Messa P. Hepatitis C Virus Infection and Kidney Disease: A Meta-Analysis. Clin J Am Soc Nephrol. 2012 Apr;7(4):549-57
  • Carrion AF, Ghanta R, Carrasquillo O, Martin P. Chronic Liver Disease in the Hispanic Population of the United States. Clin Gastroenterol Hepatol. 2011 Oct;9(10):834-41.
  • Reddy PN, Sampaio MS, Kuo H, Martin P, Bunnapradist S. Impact of Pre-Existing Hepatitis B Infection on the Outcomes of Kidney Transplant Recipients in the United States. Clin J Am Soc Nephrol. 2011 Jun;6(6):1481-7.
  • Fabrizi F, Dixit V, Martin P, Messa P. Meta-analysis: the impact of diabetes mellitus on the immunological response to hepatitis B virus vaccine in dialysis patients. Aliment Pharmacol Ther. 2011 Feb; 33(7):815–821
  • Fabrizi F, Dixit V, Martin P, Messa P. Pre-transplant Kidney Function Predicts Chronic Kidney Diesease After Liver Transplant: Meta-Analysis of Observational Studies. Dig. Disc. Sci 2011 Jan 8;56(5):1282-9.
  • Carrion AF, Czul F, Arosemena LR, Selvaggi G, Garcia MT, Tekin A, Tzakis AG, Martin P, Ghanta RK. Propylthiouracil-Induced Acute Liver Failure: Role of Liver Transplantation. Int J Endocrinology. 2010 Dec 23;2010:910636
  • Fabrizi F, Dixit V, Martin P, Messa P. Combined antiviral therapy of hepatitis C virus in dialysis patients: meta-analysis if clinical trials. J.Viral Hepatology. 2010 Nov. 25:1365-2893
  • Maganty K, Levi D, Moon J, Bejarano PA, Arosemena L, Tzakis A, Martin P. Combined Hepatocellular Carcinoma and Intrahepatic Cholangiorcarcinoma: Outcome After Liver Transplantation. Dig Dis Sci. 2010 Sep 17; 55(12):3597-601
  • Fabrizi F, Dixit V, Messa P, Martin P, Intradermal vs Intramuscular Vaccine Against Hepatitis B Infection in Dialysis Patients: A Meta-Analysis of Randomized Trials. J Viral Hepatology 2010 Aug 31: 1365-2893
  • Fabrizi F., Dixit V., Messa P., Martin P. Meta-Analysis: levamisole improves the immune response to hepatitis B vaccine in dialysis patients. Aliment. Pharmacol.Ther. 2010 Sep;32(6):756-62
  • Rao V, Fabrizi F, Pennell P, Schiff E, de Medina M, Lane JR, Martin P, Ivor L. Improved Detection of Hepatitis C Virus Infection by Transcription-Mediated Amplification Technology in Dialysis Population. Renal Failure, 2010 July, 32 (6): 721-726.
  • Pockros PJ., Hamzen FM., Martin P., Lentz E.,Zhou X., Govindarajan S., Lok AS. Histologic outcomes in hepatitis C-infected patients with varying degrees of virologic response to interferon-based treatments. Hepatology 2010 Jun 16
  • Miguel M, Santos Sampaio M, Kuo HT, Poommipanit N, Martin P, Influence of Preexisting Hepatitis C Virus Antibody Positivity in Simultaneous Pancreas-Kidney Transplant Recipients. Transplantation. 2010 May 11;90(1):61-7.
  • Fabrizi F, Dixit V, Messa P, Martin P. Pegylated Interferon Monotherapy of Chonic Hepatitis C in Dialysis Patients: Meta-Analysis of Clinical Trials. Journal of Medical Virology. 2010 May; 82 (5): 768-75
  • Kuo HT, Sampaio MS, Ye X, Reddy P, Martin P, Bunnapradist S. Risk Factors for New-Onset Diabetes Mellitus in Adult Liver Transplant Recipients, an Analysis of the Organ Procurement and Transplant Network/United Network for Organ Sharing Database. Transplantation. 2010 May 15; 89 (9):1134-40
  • Levi D, Tzakis A, Martin P, Nishida S, Island E, Moon J, Selvaggi G, Tekin A, Madrazo B, Narayanan G, Garcia M, Feun L, Tryphonopoulos P, Skartsis N, Livingstone A. Liver Transplantation for Hepatocellular Carcinoma in the MELD Era. 2010 May;210(5):727-34, 735-6.
  • Kanwal F, Kramer J, Asch SM, El-Serag H, Spiegel BM, Edmundowicz S, Sanyal AJ, Dominitz JA, McQuaid KR, Martin P, Keeffe EB, Friedman LS, Ho SB, Durazo F, Bacon BR. An Explicit Quality Indicator Set for Measurement of Quality of Care in Patients with Cirrhosis. Clin Gastroenterol Hepatol. 2010 April 10;8(8):709-17
  • Fabrizi F, Messa P, Martin P. Health-related quality of life in dialysis patients with HCV infection. Int J Artif Organs. 2009 Oct 21;32(8):473-481.
  • Tran TT, Rakoski MO, Martin P, Poordad F. Screening for hepatitis B in chemotherapy patients: survey of current oncology practices. Aliment Pharmacol Ther. 2009 Oct 8; 31(2):240-6.
  • Tan HH, Virmani S, Martin P. Controversies in the management of alcoholic liver disease. Mt Sinai J Med. 2009 Oct; 76(5):484-98.
  • Fabrizi F, Messa P, Martin P. Current status of renal transplantation from HCV-positive donors. Int J Artif Organs. 2009 May;32(5):251-61.
  • Fabrizi F, Dixit V, Messa P, Martin P. Terlipressin for hepatorenal syndrome: A meta-analysis of randomized trials. Int J Artif Organs. 2009 Mar;32(3):133-40.
  • Martin P, Fabrizi F. Progression of HCV infection in patients with chronic kidney disease. J Hepatol. 2009 Mar;50(3):622.
  • Tan HH, Chang CY, Martin P. Acetaminophen hepatotoxicity: current management. Mt Sinai J Med. 2009 Feb;76(1):75-83.
  • Rodriguez-Torres M, Jeffers LJ, Sheikh MY, Rossaro L, Ankoma-Sey V, Hamzeh FM, Martin P. Latino Study Group:Peginterferon alfa-2a and ribavirin in Latino and non-Latino whites with hepatitis C. N Engl J Med. 2009 Jan 15;360(3):257-67.
  • Fabrizi F, Lunghi G, Alongi G, Aucella F, Barbisoni F, Bisegna S, Corghi E, Faranna P, Mangano S, Romei-Longhena G, Martin P. Kinetics of hepatitis B virus load and haemodialysis: a prospective study. J Viral Hepat. 2008 Dec;15(12):917-2
  • Keeffe EB, Dieterich DT, Han SH, Jacobson IM, Martin P, Schiff ER, Tobias H. A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: 2008 update. Clin Gastroenterol Hepatol. 2008 Dec;6(12):1315-41. Quiz: 1286.
  • Fabrizi F, Lunghi G, Messa P, Martin P. Therapy of hepatitis C virus-associated glomerulonephritis: current approaches. J Nephrol. 2008 Nov-Dec; 21(6):813-25.
  • Shouval D, Lai CL, Chang TT, Cheinquer H, Martin P, Carosi G, Han S, Kaymakoglu S, Tamez R, Yang J, Tenney D, Brett-Smith H . Relapse of hepatitis B in HBeAg-negative chronic hepatitis B patients who discontinued successful entecavir treatment: The case for continuous antiviral therapy. J Hepatol. 2009 Feb;50(2):289-95
  • Martin P, Fabrizi F. Hepatitis C virus and kidney disease. J Hepatology. 2008 Oct;49(4):613-24.
  • Fabrizi F, Messa P, Martin P. Hepatitis B virus infection and the dialysis patient. Semin Dial. 2008 Sep-Oct;21(5):440-6.
  • Fabrizi F, Messa P, Martin P, Takkouche B. Hepatitis C virus infection and post-transplant diabetes mellitus among renal transplant patients: a meta-analysis. Int J Artif Organs. 2008 Aug;31(8):675-82.
  • Martin P, Jensen DM. Ribavirin in the treatment of chronic hepatitis C. J Gastroenterol Hepatol. 2008 Jun;23(6):844-55
  • Fabrizi F, Marzano A, Messa P, Martin P, Lampertico P. Hepatitis B virus infection in the dialysis population: current prospectives. Int J Artif Organs. 2008 May;31(5):386-94.
  • Carriero D, Fabrizi F, Uriel AJ, Park J, Martin P, Dieterich DT. Treatment of dialysis patients with chronic hepatitis C using pegylated interferon and low-dose ribavirin. Int J Artif Organs. 2008 Apr; 31(4):295-302.
  • Hamilton HE, Gordon C, Nelson M, Cotler SJ, Martin P. How physicians describe outcomes to HCV therapy: prevalence and meaning of "cure" during provider-patient in-office discussions of HCV. J Clin Gastroenterol. 2008 Apr; 42(4):419-24.
  • Fabrizi F, Ganeshan SV, Lunghi G, Messa P, Martin P. Antiviral therapy of hepatitis C in chronic kidney diseases: meta-analysis of controlled clinical trials. J Viral Hepat. 2008 Apr 28.
  • Fabrizi F, Dixit V, Messa P, Martin P. Interferon monotherapy of chronic hepatitis C in dialysis patients: meta-analysis of clinical trials. J Viral Hepat. 2008 Feb; 15(2):79-88.
  • Fabrizi F, Martin P. Transmission of hepatitis C virus in the hemodialysis setting. Hot Topics in Viral Hepatitis. Hepatitis C transmission: Current Issues (part 2). 2008;11:12-17.
  • Fabrizi F, Martin P. Trasmissione del virus dell’epatite C in emodialisi. Hot Topics in Viral Hepatitis. La trasmissione dell-epatite C: le problematiche attuali (parte seconda_. 2008; 11: 12-17.
  • Shaye OA, Yadegari M, Abreu MT, Poordad F, Simon K, Martin P, Papadakis KA, Ippoliti A, Vasiliauskas E, Tran TT. Hepatotoxicity of 6-mercaptopurine (6-MP) and Azathioprine (AZA) in adult IBD patients. Am J Gastroenterol. 2007 Nov;102(11):2488-94.
  • Fabrizi F, Takkouche B, Lunghi G, Dixit V, Messa P, Martin P. The impact of hepatitis C virus infection on survival in dialysis patients: meta-analysis of observational studies. J Viral Hepat. 2007 Oct;14(10):697-703.
  • Fabrizi F, Bruchfeld A, Mangano S, Dixit V, Messa P, Martin P.Interferon therapy for HCV-associated glomerulonephritis: meta-analysis of controlled trials. Int J Artif Organs. 2007 Mar; 30(3):212-9.
  • Fabrizi F, De Vecchi AF, Qureshi AR, Aucella F, Lunghi G, Bruchfeld A, Bisegna S, Mangano S, Limido A, Vigilante D, Forcella M, Delli Carri P, Martin P. Gamma glutamyltranspeptidase activity and viral hepatitis in dialysis population. Int J Artif Organs. 2007 Jan; 30(1):6-15.
  • Fabrizi F, Martin P, Messa P. Recent advances in the management of hepato-renal syndrome (HRS). Acta Clin Belg Suppl. 2007;(2):393-6.
  • Fabrizi F, Lunghi G, Dixit V, Martin P. Meta-analysis: anti-viral therapy of hepatitis C virus-related liver disease in renal transplant patients. Aliment Ph armacol Ther. 2006 Nov 15;24(10):1413-22.
  • Kanwal F, Farid M, Martin P, Chen G, Gralnek IM, Dulai GS, Spiegel BM. Treatment alternatives for hepatitis B cirrhosis: a cost-effectiveness analysis. Am J Gastroenterol. 2006 Sep;101(9):2076-89.
  • Fabrizi F, Dixit V, Martin P. Meta-analysis: anti-viral therapy of hepatitis B virus-associated glomerulonephritis. Aliment Pharmacol Ther. 2006 Sep 1;24(5):781-8.
  • Fabrizi F, Dixit V, Martin P. Meta-analysis: terlipressin therapy for the hepatorenal syndrome. Aliment Pharmacol Ther. 2006 Sep 15;24(6):935-44.
  • Fabrizi F, Ganeshan SV, Dixit V, Martin P. Meta-analysis: the adjuvant role of granulocyte macrophage-colony stimulating factor on immunological response to hepatitis B virus vaccine in end-stage renal disease. Aliment Pharmol Ther. 2006 Sep 1; 24(5):789-96.
  • Keeffe EB, Dieterich DT, Han SH, Jacobson IM, Martin P, Schiff ER, Tobias H, Wright TL. A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: an update. Clin Gastroenterol Hepatol. 2006 Aug;4(8):936-62.
  • Fabrizi F, Dixit V, Magnini M, Elli A, Martin P. Meta-analysis: intradermal vs. intramuscular vaccination against hepatitis B virus in patients with chronic kidney disease. Aliment Pharmol Ther. 2006 Aug 1; 24(3):297-506.
  • Fabrizi F, Mangano S, Aucella F, Dixit V, Martin P. Hepatitis C virus infection and diabetes mellitus in end-stage renal disease: evidence of a negative association. Int J Artif Organs. 2006 Jul;29(7):691-7.
  • Sherman M, Yurdaydin C, Sollano J, Silva M, Liaw YF, Cianciara J, Boron-Kaczmarska A, Martin P, Goodman Z, Colonno R, Cross A, Denisky G, Kreter B, Hindes R. Entecavir for treatment of lamivudine-refractory, HBeAg-positive chronic hepatitis B. Gastroenterology. 2006 Jun;130(7):2039-49.
  • Fabrizi F, Dixit V, Martin P. Meta-analysis: the adjuvant role of thymopentin on immunological response to hepatitis B virus vaccine in end-stage renal disease. Aliment Pharmacol Ther. 2006 Jun 1;23(11):1559-66.
  • Puliyanda DP, Amet N, Dhawan A, Hilo L, Radha RK, Bunnapradist S, Czer L, Martin P, Jordan S, Toyoda M. Isolated heart and liver transplant recipients are at low risk for polyomavirus BKV nephropathy. Clin Transplant. 2006 May-Jun;20(3):289-94.
  • Fabrizi F, Dixit V, Bunnapradist S, Martin P. Meta-analysis: the dialysis mode and immunological response to hepatitis B virus vaccine in dialysis population. Aliment Pharmacol Ther. 2006 Apr 15;23(8):1105-12.
  • Hamilton HE, Nelson M, Martin P, Cotler SJ. Provider-patient in-office discussions of response to hepatitis C antiviral therapy and impact on patient comprehension. Clin Gastroenterol Hepatol. 2006 Apr;4(4):507-13.
  • Tran TT, Changsri C, Shackleton CR, Poordad FF, Nissen NN, Colquhoun S, Geller SA, Vierling JM, Martin P. Living donor liver transplantation: histological abnormalities found on liver biopsies of apparently healthy potential donors. J Gastroenterol Hepatol. 2006 Feb;21(2):381-3.
  • Binesh N, Huda A, Thomas MA, Wyckoff N, Bugbee M, Han S, Rasgon N, Davanzo P, Sayre J, Guze B, Martin P, Fawzy F. Hepatic encephalopathy: a neurochemical, neuroanatomical, and neuropsychological study. J Appl Clin Med Phys. 2006 Winter;7(1):86-96.
  • Fabrizi F, Lunghi G, Dixit V, Martin P. Terapia di HCV e insufficienza renale: recent acquisizioni. Giornale Techniche Neforlogiche e Dialiche. 2006; 3: 33-37.
  • Fabrizi F, Martin P, Dixit V, Kanwal F, Dulai G. HBsAg seropositive status and survival after renal transplantation: meta-analysis of observational studies. AM J Transplant. 2005 Dec; 5(12):2913-21.
  • Fabrizi F, Martin P, Dixit V, Bunnapradist S, Kanwal F, Dulai G. Post-transplant diabetes mellitus and HCV seropositive status after renal transplantation: meta-analysis of clinical studies. Am J Transplant. 2005 Oct;5 (10): 2433-40.
  • Fabrizi F, Martin P, Dixit V, Bunnapradist S, Dulai G. Hepatitis C virus antibody status and survival after renal transplantation: meta-analysis of observational studies. Am J Transplant. 2005 Jun;5 (6):1452-61.
  • Fabrizi F, Messa PG, Lunghi G, Aucella F, Bisegna S, Mangano S, Villa M, Barbisoni F, Rusconi E, Martin P. Occult hepatitis B in virus infection in dialysis patients: a multicentre survey. Aliment Pharmocol Ther. 2005 Jun 1;21(11):1341-7.
  • Kanwal F, Gralnek IM, Martin P, Dulai GS, Farid M, Spiegel BM. Treatment alternatives for chronic hepatitis B virus infection: a cost-effectiveness analysis. Ann Intern Med. 2005;142(10):821-31.
  • Fabrizi, F, Martin P, Dixit V, Bunnapradist S, Kanwal F, Dulai G. Post-transplant diabetes mellitus and HCV seropositive status after renal transplantation: meta-analysis of clinical studies. Am J Transplant. 2005;5(10):2433-40
  • Shackleton CS, Vierling JM, Nissen N, Martin P, Poordad F, Tran T, Colquhoun SD. Morbidity in live liver donors: standards-based adverse event reporting further defined. Arch Surg. 2005;140:888-95.
  • Jutabha R, Jensen DM, Martin P, Savides T, Han SH, Gornbein J. Randomized study comparing banding and propranolol to prevent initial variceal hemorrhage in cirrhotics with high-risk esophageal varices. Gastroenterology. 2005 Apr; 128(4):870-81.
  • Fabrizi F, de Vecchi AF, Como G, Lunghi G, Martin P. De novo HCV infection among dialysis patients: a prospective study by HCV core antigen ELISA assay. Aliment Pharmacol Ther. 2005 Apr 1;21(7):861-9.
  • Fabrizi F, Lunghi G, Aucella F, Mangano S, Barbisoni F, Bisegna S, Vigilante D, Limido A, and Martin P. Novel assay using total hepatitis C virus (HCV) Core Antigen quantification for Diagnosis of HCV Infection in Dialysis Patients. Journal of Clinical Microbiology. 2005; 43(1): 414-420.
  • Chalasani N, Manzarbeitia C, Ferenci P, Vogel W, Fontana RJ, Voigt M Riely C, Martin P, Teperman L, Jiao J, Lopez-Talavera JC. Peginterferon alfa-2a for hepatitis C after liver transplantation: Two randomized, controlled trails. Hepatology. 2005 Jan 19;41 (2):289-298.
  • Fabrizi F, Martin P, Dixit V, Bunnapradis S, Dulai G. Meta-analysis: the effect of age on immunological response to hepatitis B vaccine in end-stage renal disease. Aliment Pharmacol Ther. 2004 Nov 15;20(10):1053-62.
  • Martin P, Busuttil RW, Goldstein RM, Crippin JS, Klintmalm GB, Fitzsimmons WE, Uleman C. Impact of tacrolimus versus cyclosporine in hepatitis C virus-infected liver transplant recipients on recurrent hepatitis: A Prospective, randomized trial. Liver Transpl. 2004 Oct;10(10):1258-1262.
  • Fabrizi F, Martin P, Lunghi G, Guerra L, De Vecchi AF, Ponticelli C. HCV-related liver in hemodialysis population: Clinical and biochemical characteristics. G Ital Nefol. 2004 Sep-Oct;21(5):283-7.
  • Fabrizi F, Bunnapradist S, Lunghi G, Aucella F, Martin P. Epidemiology and clinical significance of hepatotropic infections in dialysis patients: Recent evidence. Minerva Urol Nefrol. 2004 Sep;56(3):249-57.
  • Fabrizi F, Dulai G, Dixit V, Bunnapradist M, Martin P. Lamivudine for the treatment of HBV-related liver disease after renal transplantation: meta-analysis of clinical trials. Transplantation. 2004 Mar 27;77(6):859-864.
  • Fabrizi F, Martin P, Lunghi G, Ponticelli C. Natural history of HBV in dialysis population. G Ital Nefrol. 2004 Jan-Feb;21(1):21-8.
  • Peters MG, Hann HW, Martin P, Heathcote E, Buggisch P, Rubin R, Bourliere M, Kowdley K, Trepo C, Gray DF, Sullivan M, Kleber K, Ebrahimi R, Xiong S, Brosgart CL. Adefovir Dipivoxil alone or in combination with lamivudine in patients with lamivudine-resistant hepatitis B virus. Gastroenterology. 2004;126(1):91-101.
  • Geller S, Dubinsky M, Poordad FF, Vasiliauskas E, Cohen A., Abreu M, Tran, T, Martin P, Vierling J, Targan S. Early hepatic nodular hyperplasia and submicroscopic fibrosis associated with 6-thioguanine therapy in inflammatory bowel disease. Am J Surg Pathol. 2004;28:1204-1211
  • Fabrizi F, Martin P, Dixit V, Bunnapradist S, Dulai G. Meta-analysis: Effect of hepatitis C virus infection on mortality dialysis. Aliment Pharmacol Ther. 2004;20:1271-7.
  • Firpi RJ, Tran T, Flores P, Nissen N, Colquhoun S, Shackleton C, Martin P, Vierling J, Poordad FF. Sirolimus-induced hyperlipidemia in liver transplant recipients is not dose-dependent. Alimentary Pharmacology and Therapeutics. 2004;19(9):1033-9.
  • Fabrizi F, Martin P, Lunghi G, Aroldi A, Messa P. Hepatitis C virus and renal transplantation. G Ital Nefrol. 2004;21(5):429-37.
  • Han SH, Martin P, Edelstein M, Hu R, Kunder G, Holtz C, Saab S, Durazo F, Goldstein L, Farmer D, Ghobrial RM, Busuttil R. Conversion From Intravenous to Intramuscular Hepatitis B Immune Globulin in Combination With Lamivudine Is Safe and Cost-Effective in Patients Receiving Long-term Prophylaxis to Prevent Hepatitis B Recurrence After Liver Transplantation. Liver Transplantation. 2003;9(2):182-187.
  • Poordad FF, Gish RB, Wakil E, Martin P, Yao F. De novo Non-alcoholic fatty liver disease following orthotopic liver transplantation. American J of Transplantation. 2003;3(11):1407-1412.
  • Dubinsky MC, Vasiliauskas EA, Singh H, Abreu MT, Papadakis KA, Tran T, Martin P, Vierling JM, Geller SA, Targan SR, Poordad FF. 6-Thioguanine can cause serious liver injury in inflammatory bowel disease patients. Gastroenterology. 2003;125(2):298-303.
  • Di Bisceglie A, Lyra AC, Schwartz M, Reddy RK, Martin P, Gores G, Lok AS, Hussain KB, Gish R, Van Thiel D, Younossi Z, Tong M, Hassanein T, Balart L, Fleckenstein J, Flamm S, Blei A, Befeler AS. Hepatitis C-Related Hepatocellular Carcinoma in the United States: Influence of Ethnic Status. Am J of Gastro. 2003;98(9):2060-2063.
  • Fabrizi F, Dulai G, Dixit V, Bunnapradist S, Martin P. Meta-analysis: interferon for the treatment of chronic hepatitis C in dialysis patients. Aliment Pharmacol Ther. 2003;18(11-12):1071-1081.
  • Ly D, Yee HF Jr., Brezina M, Martin P, Gitnick G, Saab S. Hepatitis B surface antigenemia in chronic hemodialysis patients: effect of hepatitis B immunization. Am J Gastro. 2002;97(1):138-141.
  • Bunnapradist S, Fabrizi F, Vierling J, Martin P, Moudgil A, Kamili S, Jordan S. Hepatitis C therapy with long term remission after renal transplantation. Int J Artif Organs. 2002;25(12):1189-1193.
  • Fabrizi F, Lunghi G, Martin P. TT virus infection in end-stage renal disease (ESRD). J Nephrol. 2001 Mar-Apr;14(2):80-7.
  • Fabrizi F, Martin P, Dixit V, Quan S, Brezina M, Kaufman E, Sra K, Mousa M, DiNello R, Polito A, Gitnick G. Automated RIBA HCV strip immunoblot assay: a novel tool for the diagnosis of hepatitis C virus infection in hemodialysis patients. Am J Nephol. 2001 Mar-Apr;21(2):104-11.
  • Perrillo R, Wright T, Rakela J, Levy G, Schiff E, Gish R, Martin P, Dienstag J, Adams P, Dickson R, Anschuetz G, Bell S, Condreay L, Brown N. A multicenter United States-Canadian trial to assess lamivudine monotherapy before and after liver transplantation for chronic hepatitis B. Hepatology. 2001;33(2):424-432.
  • Thomas MA, Yue K, Binesh N, Davanzo P, Kumar A, Siegel B, Frye M, Curran J, Lufkin R, Martin P, Guze B. Localized two-dimensional shift correlated MR spectroscopy of human brain. Magn Reson Med. 2001; 46:58-67.
  • Shimoda M, Saab S, Morrissey M, Ghobrial M, Farmer D, Chen P, Han S, Bedford R, Goldstein L, Martin P, Busuttil R. A Cost-effectiveness Analysis of Biliary Anastomosis With or Without T-tube after Orthotopic Liver Transplantation. Am J Transp. 2001;1(2):157-161.
  • Martin P, Carter D, Fabrizi F, Dixit V, Conrad A, Artinian L, Peacock V, Han S, Wilkinson C, Lassman R, Danovitch G. Histopathological features of hepatitis C in renal transplant candidates. Transplantation. 2000 Apr;69(7):1479-1484.
  • Gralnek IM, Hays RD, Sehyun K, Rosen HR, Keeffe EB, Artinian L, Lazarovici D, Jensen DM, Busuttil RW, Martin P. Development and evaluation of the liver disease quality of life instrument, LDQOL 1.0. Am J Gastroenterology. 2000;(12):3552-65.
  • Saab S, Martin P, Soliman G, Machicado G, Roth B, Kunder G, Han S, Farmer D, Ghobrial RM, Busuttil RW, Bedford R. Endoscopic management of biliary leaks following T-Tube removal in liver transplant recipients: nasobiliary drainage vs biliary stenting. Liver Transpl. 2000;6(5):627-632.
  • Fabrizi F, Martin P, Quan S, Dixit V, Brezina M, Conrad A, Polito A, Gitnick G. Serotyping strip immunoblot assay for assessing hepatitis C virus stains in dialysis patients. Am J Kidney Dis. 2000;35(5):832-838.
  • Fabrizi F, Martin P, Dixit V, Brezina M, Cole M, Vinson S, Mousa M, Gitnick G. Biological dynamics of viral load in hemodialysis patients with hepatitis C virus. Am J Kidney Dis. 2000; 35(1):122-9.
  • Vasilopoulos S, Hally R, Caro J, Martin P, Westerberg S, Moritz M, Jarrell B, Muñoz S. Erythropoietin response to post-liver transplantation anemia. Liver Transplantation. 2000;6(3):349-355.
  • Saab S, Martin P, Yee H. A simple cost-decision analysis model comparing two strategies for hepatitis A vaccination. Am J Med. 2000;109(3):241-244.
  • Han SH, Ofman J, Holt C, King K, Kunder G, Chen P, Dawson S, Goldstein L, Yersiz H, Farmer DG, Ghobrial RM, Busuttil RW, Martin P. An efficacy and cost-effectiveness analysis of combination hepatitis B immune globulin and Lamivudine to prevent recurrent hepatitis B after orthotopic liver transplantation compared with hepatitis B immune globulin monotherapy. Liver Transpl. 2000;6(6):741-748.
  • Fabrizi F, Martin P, Dixit V, Brezina M, Russell J, Conrad A, Schmid P, Gerosa S, Gitnick G. Detection of de novo hepatitis C virus infection by polymerase chain reaction in hemodialysis patients. American Journal of Nephrology. 1999;19(3):383-388.
  • Perrillo R, Rakela J, Dienstag J, Levy G, Martin P, Wright T, Caldwell S, Schiff E, Gish R, Villeneuve JP, Farr G, Anschutz G, Self P, Brown N. Multicenter study of lamivudine therapy for recurrent hepatitis B after liver transplantation. Hepatology. 1999;29(5):1581-6.
  • Markmann JF, Gornbein J, Markowitz JS, Levy MF, Klintmalm GB, Yersiz M, Morrisey M, Drazan K, Farmer DG, Ghobrial M, Goss J, Seu P, Martin P, Goldstein LI, Busuttil RW. A simple model to estimate survival following retransplantation of the liver. Transplantation. 1999;Feb 15;67(3):422-30.
  • Fabrizi F, Martin P, Dixit V, Quan S, Brezina M, Abbey H, Gerosa S, Kaufman E, DiNello R, Polito A, Gitnick G. Epidemiology of helicobacter pylori in chronic hemodialysis patients using the new RIBA H. pylori SIA. Nephrol Dial Transplant. 1999 Aug;14(8):1929-33.
  • Ghobrial RM, Farmer DG, Baquerizo A, Colquhoun S, Rosen H, Yersiz H, Markmann JF, Drazan K, Holt CD, Imagawa D, Goldstein LI, Martin P, Busuttil RW. Orthotopic Liver Transplantation for Hepatitis C: Outcome, effect of immunosuppression and causes of retransplantation during an eight-year single center experience. Annals of Surgery. 1999;229(6):824-833.
  • Gralnek IM, Liu HH, Shapiro MF, Martin P. The United States liver donor population in the 1990s: a descriptive, population-based comparative study. Transplantation. 1999;67(7):1019-1023.
  • Martin P, Fabrizi F, Dixit V, Brezina M, Gerosa S, Russell J, Conrad A, Gitnick G. Epidemiology and Natural History of Hepatitis G Virus Infection in Chronic Hemodialysis Patients. Am J Nephrol. 1999;19(5):535-540.
  • Rosen HR, Madden JP, Martin P. A model to predict survival following liver retransplantation. Hepatology. 1999;29:365-70.
  • Fabrizi F, Martin P, Dixit V, Brezina M, Cole MJ, Gerosa S, Vinson S, Mousa M, Gitnick G. Quantitative assessment of HCV Load in chronic hemodialysis patients: A cross-sectional survey. Nephron. 1998; 80(4):428-433.
  • Martin P, Hann HW, Munoz SJ, Westerberg S, Maddrey WC. Interferon-alpha 2b therapy is efficacious in Asian-Americans with chronic hepatitis B infection: a prospective controlled study. Digestive Diseases and Sciences .1998;43: 875-879.
  • Fabrizi F, Martin P, Dixit V, Brezina M, Cole MJ, Gerosa S, Mousa M, Gitnick G. Acquisition of hepatitis C virus in hemodialysis patients: a prospective study by branched DNA signal amplification assay. American Journal of Kidney Diseases. 1998 Apr;31(4):647-654.
  • Rosen HR, Martin P, Goss J, Donovan J, Melinek J, Rudich S, Imagawa DK, Kinkhabwala M, Seu P, Busuttil RW, Shackleton CR. Significance of early aminotransferase elevation after liver transplantation 1. Transplantation. 1998;65(1):68-72.
  • Martin P, Fabrizi F, Dixit V, Quan S, Brezina M, Kaufman E, Sra K, Di Nello R, Gitnick G. Automated RIBA hepatitis C virus (HCV) strip immunoblot assay for reproducible HCV diagnosis. Journal of Clinical Microbiology. 1998 Feb;36(2):387-390.
  • Markowitz JS, Martin P, Conrad AJ, Markmann JF, Seu P, Yersiz H, Goss JA, Pakrasi A, Artinian L, Murray NGB, Imagawa DK, Holt C, Goldstein LI, Stribling R, Busuttil. Prophylaxis against hepatitis B recurrence following liver transplantation using combination lamivudine and hepatitis B immune globulin. Hepatology. 1998;28:585-9.
  • Rosen HR, Martin P. Hepatitis C infection in patients undergoing liver retransplantation. Transplantation. 1998; 66(12):1612-1616.
  • Thomas MA, Huda A, Guze B, Curran J, Bugbee M, Fairbanks L, Yong K, Oshiro T, Martin P, Fawzy F. Cerebral 1H MR spectroscopy and neuropsychological status of hepatic encephalopathy. American J. Roentgenology. 1998;171:1123-1130.
  • Markowitz JS, Seu P, Goss JA, Yerriz H, Markmann JF, Farmer DG, Ghobrial RM, Goldstein LI, Martin P, Stribling R, Busuttil RW. Liver transplantation for decompensated cirrhosis following jejunoileal bypass: a strategy for management. Transplantation. 1998;65(4):570-572.
  • Swenson K, Seu P, Kinkhabwala M, Maggard M, Martin P, Goss J, Busuttil RW. Liver transplantation for adult polycystic liver disease. Hepatology. 1998;28(2):412-5.
  • Goss JA, Shackleton CR, Farmer DG, Arnaout WS, Seu P, Markowitz JS, Martin P, Stribling RJ, Goldstein LI, Busuttil RW. Orothotopic liver transplantation for primary sclerosing cholangitis; a twelve year single center experience. Annals of Surgery. 1997;225(5):472-483.
  • Holt C, Winston D, Kubak B, Imagawa D, Martin P, Goldstein LI, Olthoff K, Millis JM, Shaked A, Shackleton C, Busuttil R. Coccidiomycosis in Liver Transplant Recipients. Clinical Infectious Diseases. 1997;24(2):216-21.
  • Rosen HR, Holt C, Shackleton C, McDiarmid S, Gralnek I, Busuttil RW, Martin P. Use of OK3T is associated with severe hepatitis C recurrence after liver transplantation. American Journal of Gastroenterology. 1997;92(9):1453-1457.
  • Markmann JF, Markowitz JS, Yersiz H, Morrissey M, Farmer D, Farmer DA, Goss J, Ghobrial R, McDiarmid S, Stribling R, Martin P, Goldstein LI, Seu P, Shackleton C, Busuttil RW. Long term survival following retransplantation of the liver. Annals of Surgery. 1997;226(4):408-420.
  • Goss JA, Schiller G, Martin P, Seu P, Stribling R, McDiarmid S, Shackleton CR, Markowitz JS, Nuesse BJ, Goldstein L, Busuttil RW. Aplastic anemia complicating orthotopic liver transplantation. Hepatology. 1997;26(4):865-869.
  • Rosen HR, Martin P, Shackleton CR, Holt C, Schiller G, Territo M, Busuttil RW. Orthotopic liver transplantation for bone-marrow transplant-associated veno-occlusive disease and graft-versus-host disease of the liver. Liver Transplantation and Surgery. 1996;2(3):225-232.
  • Jurim O, Martin P, Winston DJ, Shackleton C, Holt C, Feller J, Csete M, Shaked A, Imagawa D, Olthoff K, Lau JYN, Busuttil RW. Failure of ganciclovir prophylaxis to prevent allograft reinfection following orthotopic liver transplantation for chronic hepatitis B infection. Liver Transplantation and Surgery. 1996;2(5):370-374
  • Rosen HR, O'Reilly PM, Shackleton CR, McDiarmid S, Holt C, Busuttil RW, Martin P. Graft loss following liver transplantation in patients with chronic hepatitis C. Transplantation. 1996;62(12):1773-6.
  • Imagawa DK, Dawson S, Holt CD, Kirk PS, Kaldos FM, Shackleton CR, Seu P, Rudich SM, Kinkhabwala MM, Martin P, Goldstein LI, Murray NGB, Terasaki PI, Busuttil RW. Hyperlipidemia after liver transplantation, natural history and treatment with the hydroxy-methylgutaryl-coenzyme A reductase inhibitor Pravastatin. Transplantation. 1996;62(7):934-942.
  • Millis M, Martin P, Gomes A, Shaked A, Colquhoun SD, Goldstein LI, Busuttil R. Transjugular intrahepatic portosystemic shunts: impact on liver transplantation. Liver Transplantation and Surgery. 1995;1(4):229-233.
  • Olthoff KM, Rosove MH, Shackleton CR, Imagawa DK, Farmer DG, Northcross P, Pakrasi AL, Martin P, Goldstein LI, Shaked A, Busuttil RW. Adjuvant chemotherapy improves survival following liver transplantation for hepatocellular carcinoma. Annals of Surgery. 1995;221(6):734-743.
  • McDiarmid SV, Farmer DA, Goldstein L, Martin P, Vargas J, Tipton JR, Simmons F, Busuttil RW. A randomized prospective trial of steroid withdrawal after liver transplantation. Transplantation. 1995;60(12):1443-1450.
  • Yersiz H, Shaked A, Olthoff K, Imagawa D, Shackleton C, Martin P, Busuttil RW. Correlation between donor age and the pattern of liver graft recovery after transplantation. Transplantation. 1995;60(8):790-794.
  • Dixit V, Quan S, Martin P, Larson D, Brezina M, Dinello R, Sra K, Lau JYN, Chien D, Kolberg J, Tagger A, Davis G, Polito A, Gitnick G. Evaluation of a novel serotyping system for hepatitis C virus: Strong correlation with standard genotyping methodologies. Journal of Clinical Microbiology. 1995;33(11):2978-2983.
  • Shackleton CR, Martin P, Melinek J, Millis MJ, Olthoff KM, Imagawa DK, Jurim O, Shaked A, McDiarmid S, Goldstein LI, Busuttil RW. Lack of correlation between the magnitude of preservation injury and the incidence of acute rejection, need for OKT3 or conversion to FK506 in cyclosporine treated primary liver allograft recipients. Transplantation. 1995;60(6):554-558.
  • Jurim O, Martin P, Shaked A, Goldstein L, Millis JM, Calquhoun SD, Gitnick G, Tong MJ, Busuttil RW. Liver transplantation for chronic hepatitis B in Asians. Transplantation. 1994;57:1393-1395.
  • DeVault KR, Friedman LS, Westerberg S, Martin P, Hosein B, Ballas SK. Hepatitis C in sickle cell anemia. J Clinical Gastroenterology. 1994;18:206-209.
  • Munoz SJ, Moritz MJ, Bell R, Northrup B, Martin P., Radomski J. Factors associated with severe intracranial hypertension in candidates for emergency liver transplantation. Transplantation. 1993;55(5):1071-1074.
  • Lucey MR, Graham DM, Martin P, Di Bisceglie AM, Rosenthal S, Waggoner JG, Merion RM, Campbell DA, Nostrant TT, Appelman H. Recurrence of hepatitis B and delta hepatitis following orthotopic liver transplantation. Gut. 1992;33:1390-1396.
  • Munoz SJ, Robinson M, Northup B, Bell R, Moritz M, Jarrell B, Martin P, Maddrey WC. Elevated intracranial pressure and computed tomography of the brain in fulminant hepatic failure. Hepatology. 1991;13(2):210-212.
  • Martin P, Munoz SJ, Di Bisceglie AM, Rubin R, Waggoner JG, Armenti VT, Moritz MJ, Jarrell BE, Maddrey WC. Recurrence of hepatitis C after orthotopic liver transplantation. Hepatology. 1991; 13(4):719-721.
  • Di Bisceglie AM, Martin P, Lisker-Melman M, Kassianides C, Korenman J, Bergasa NV, Baker B, Hoofnagle JH. Treatment of chronic delta hepatitis with interferon alfa-2b: a pilot study. J Hepatology. 1990;11:S151-154.
  • Di Bisceglie, AM, Martin P, Kassianides C, Lisker-Melman M, et al. A randomized, double blind, placebo-controlled trial of recombinant alpha interferon for chronic non-A, non-B (type C) hepatitis. J Hepatology. 1990;11:S36-S42.
  • Lisker-Melman M, Di Bisceglie AM, Kassianides C, Martin P, Hoofnagle JH. Glomerulonephritis caused by chronic hepatitis B virus infection: treatment with recombinant human alpha-interferon. Ann Intern Med. 1989; 111(6):479-483.
  • Di Bisceglie AM, Martin P, Kassianides C, Lisker-Melman M, et al. A randomized, double blind, placebo-controlled trial of recombinant alpha interferon for chronic non-A, non-B (type C) hepatitis. New Engl J Med. 1989; 321(22):1506-1510.
  • Martin P, Di Bisceglie AM, Kassianides C, Lisker-Melman M, Hoofnagle JH. Rapidly progressive non-A, non-B hepatitis in HIV positive patients. Gastroenterology. 1989;97(6):1559-1561.

E-mail a Friend